Division of Gynecologic Oncology, The University of Miami Sylvester Comprehensive Cancer Center, 1121 NW 14th St, Suite 345, Miami, FL, 33136, USA.
Department of Gynecologic Oncology and Reproductive Science, The University of Texas MD Anderson Cancer Center, Unit 1362, 1515 Hermann Pressler Dr, Houston, TX, 77030, USA.
BMC Cancer. 2018 Apr 3;18(1):375. doi: 10.1186/s12885-018-4313-x.
With ongoing healthcare reform and shrinking numbers of oncologists, appropriate triaging of gynecologic cancer survivor care is crucial. Input from patients is a necessary part of this task. The objective of this study was to assess the preferences of gynecologic cancer survivors for surveillance after the completion of treatment.
A 38-item questionnaire was developed and launched in conjunction with the Foundation for Women's Cancer (FWC). All women who registered as gynecologic cancer survivors with the FWC were invited to participate. Patients were asked about physician preferences for multiple symptoms and diagnoses, and when they felt comfortable transferring care out of their oncologists' offices. Analyses were performed with chi-square and logistic regression.
Six hundred twenty four patients completed the questionnaire. Sixty six percent had ovarian cancer, and 86% were primarily treated by a gynecologic oncologist. Fifty seven percent of the respondents reported being unwilling to see a physician other than their oncologist for survivorship care at any time. Women age > 60 years were less willing to leave their oncologists for survivorship care at any time compared to younger women (OR 1.53 [95% CI 1.03-2.27], p = 0.03). Ovarian cancer survivors were also more likely to report a desire to stay with their oncologists compared with uterine cancer survivors (p < 0.001). With few exceptions, respondents preferred management of non-oncologic medical problems by their oncologists.
Gynecologic cancer survivors prefer that their oncologists remain heavily involved in survivorship care. Reconciling patient needs with physician and financial constraints will be a challenge as the survivor population continues to grow.
随着医疗改革的持续推进和肿瘤学家人数的减少，对妇科癌症幸存者护理进行适当的分诊至关重要。患者的意见是这项任务的必要组成部分。本研究的目的是评估妇科癌症幸存者对治疗完成后监测的偏好。
开发了一个 38 项的问卷，并与女性癌症基金会（FWC）合作推出。所有在 FWC 注册为妇科癌症幸存者的女性都被邀请参加。患者被问及医生对多种症状和诊断的偏好，以及他们何时愿意将护理从肿瘤医生的办公室转出。使用卡方检验和逻辑回归进行分析。
624 名患者完成了问卷。66%的患者患有卵巢癌，86%的患者主要由妇科肿瘤学家治疗。57%的受访者表示，在任何时候都不愿意看医生以外的人进行生存护理。与年轻女性相比，年龄大于 60 岁的女性在任何时候都更不愿意离开肿瘤医生进行生存护理（OR 1.53[95%CI 1.03-2.27]，p=0.03）。卵巢癌幸存者也比子宫癌幸存者更有可能报告希望继续由肿瘤医生进行治疗（p<0.001）。除了少数例外，受访者更希望由他们的肿瘤医生来管理非肿瘤医学问题。
妇科癌症幸存者希望他们的肿瘤医生继续积极参与生存护理。随着幸存者人数的不断增加，如何协调患者的需求与医生和财务限制将是一个挑战。
